Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

228 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Riboflavin lowers blood pressure in cardiovascular disease patients homozygous for the 677C-->T polymorphism in MTHFR.
Horigan G, McNulty H, Ward M, Strain JJ, Purvis J, Scott JM. Horigan G, et al. Among authors: purvis j. J Hypertens. 2010 Mar;28(3):478-86. doi: 10.1097/HJH.0b013e328334c126. J Hypertens. 2010. PMID: 19952781
Serum levels of miR-199a-5p correlates with blood pressure in premature cardiovascular disease patients homozygous for the MTHFR 677C > T polymorphism.
Lynch SM, Ward M, McNulty H, Angel CZ, Horigan G, Strain JJ, Purvis J, Tackett M, McKenna DJ. Lynch SM, et al. Among authors: purvis j. Genomics. 2020 Jan;112(1):669-676. doi: 10.1016/j.ygeno.2019.04.019. Epub 2019 Apr 25. Genomics. 2020. PMID: 31029863 Clinical Trial.
Riboflavin offers a targeted strategy for managing hypertension in patients with the MTHFR 677TT genotype: a 4-y follow-up.
Wilson CP, Ward M, McNulty H, Strain JJ, Trouton TG, Horigan G, Purvis J, Scott JM. Wilson CP, et al. Among authors: purvis j. Am J Clin Nutr. 2012 Mar;95(3):766-72. doi: 10.3945/ajcn.111.026245. Epub 2012 Jan 25. Am J Clin Nutr. 2012. PMID: 22277556 Clinical Trial.
Effectiveness of double bolus alteplase in the treatment of acute myocardial infarction.
Purvis JA, Trouton TG, Roberts MJ, McKeown P, Mulholland MG, Dalzell GW, Wilson CM, Patterson GC, Webb SW, Khan MM, et al. Purvis JA, et al. Am J Cardiol. 1991 Dec 15;68(17):1570-4. doi: 10.1016/0002-9149(91)90311-8. Am J Cardiol. 1991. PMID: 1746456
Efficacy of 100 mg of double-bolus alteplase in achieving complete perfusion in the treatment of acute myocardial infarction.
Purvis JA, McNeill AJ, Siddiqui RA, Roberts MJ, McClements BM, McEneaney D, Campbell NP, Khan MM, Webb SW, Wilson CM, et al. Purvis JA, et al. J Am Coll Cardiol. 1994 Jan;23(1):6-10. doi: 10.1016/0735-1097(94)90495-2. J Am Coll Cardiol. 1994. PMID: 8277097
Anaphylactoid reaction after injection of alteplase.
Purvis JA, Booth NA, Wilson CM, Adgey AA, McCluskey DR. Purvis JA, et al. Lancet. 1993 Apr 10;341(8850):966-7. doi: 10.1016/0140-6736(93)91263-l. Lancet. 1993. PMID: 8096306 No abstract available.
Lipid peroxidation and antioxidant status following thrombolytic therapy for acute myocardial infarction.
Young IS, Purvis JA, Lightbody JH, Adgey AA, Trimble ER. Young IS, et al. Among authors: purvis ja. Eur Heart J. 1993 Aug;14(8):1027-33. doi: 10.1093/eurheartj/14.8.1027. Eur Heart J. 1993. PMID: 8404932
Novel and Innovative Dosing Regimens in Thrombolytic Therapy for Acute Myocardial Infarction.
Purvis JA. Purvis JA. J Thromb Thrombolysis. 1995;1(2):145-151. doi: 10.1007/BF01062571. J Thromb Thrombolysis. 1995. PMID: 10603523 No abstract available.
Asystolic arrest as a presentation of sarcoidosis.
McDougall NI, Purvis JA, Wilson CM, Adgey AA. McDougall NI, et al. Among authors: purvis ja. Int J Cardiol. 1994 Dec;47(2):165-7. doi: 10.1016/0167-5273(94)90184-8. Int J Cardiol. 1994. PMID: 7721485
Congestive heart failure due to aortic incompetence with intestinal infarction due to endarteritis obliterans.
Purvis JA, Adgey AA, O'Hara MD. Purvis JA, et al. Int J Cardiol. 1991 Mar;30(3):356-8. doi: 10.1016/0167-5273(91)90017-j. Int J Cardiol. 1991. PMID: 1676020
228 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page